1.Consecutive nightly measurements are needed for accurate evaluation of nocturnal erectile capacity when the first-night laboratory recording is abnormal.
Zi-Jun ZOU ; Shi-Tao CHEN ; Gong-Chao MA ; Yu-Fen LAI ; Xiao-Jian YANG ; Jia-Rong FENG ; Zhi-Jun ZANG ; Tao QI ; Bo WANG ; Lei YE ; Yan ZHANG
Asian Journal of Andrology 2020;22(1):94-99
Multiple measurements of nocturnal penile tumescence and rigidity (NPTR) are widely accepted as a method to differentiate psychogenic erectile dysfunction (ED) from organic ED. However, direct evidence remains limited regarding the first-night effect on NPTR measurement using the RigiScan. Here, we evaluated the first-night effect on the results of NPTR measurement to validate the necessity of NPTR measurement for two consecutive nights, particularly when abnormal first-night measurements are recorded in a laboratory setting. We retrospectively reviewed 105 patients with a complaint of ED, who underwent NPTR measurement using the RigiScan in the Department of Infertility and Sexual Medicine, the Third Affiliated Hospital of Sun Yat-sen University (Guangzhou, China), for two consecutive nights, during the period from November 2015 to May 2016. NPTR parameters were collected and analyzed. We found that more effective nocturnal erections were detected during the second night than during the first night (P <0.001). Twenty percent of all patients had no effective erection during the first night, but exhibited at least one effective erection during the second night. The negative predictive value of NPTR measurement during the first night was 43.2%; this was significantly lower than that on the second night (84.2%; P = 0.003). Most NPTR parameters were better on the second night than on the first night. The first-night effect might be greater among patients younger than 40 years of age. In conclusion, two consecutive nightly measurements of NPTR can avoid a false-abnormal result caused by the first-night effect; moreover, these measurements more accurately reflect erectile capacity, especially when the first-night record is abnormal in a laboratory setting.
Adult
;
Diagnosis, Differential
;
Diagnostic Techniques, Urological
;
Erectile Dysfunction/etiology*
;
Humans
;
Male
;
Penile Erection
;
Predictive Value of Tests
;
Reproducibility of Results
;
Retrospective Studies
;
Sexual Dysfunction, Physiological/diagnosis*
;
Sexual Dysfunctions, Psychological/diagnosis*
;
Sleep
;
Young Adult
2.Sleep, Sleep Disorders, and Sexual Dysfunction
The World Journal of Men's Health 2019;37(3):261-275
Good sleep is necessary for good health. Sleep health is increasingly recognized as important for physical and mental health by both the medical profession and the general public, and there is great interest in how to avoid and treat sleep disorders and problems. Recent research indicates that insufficient sleep, disrupted sleep, and sleep disorders affect many aspects of human health including sexual function. In fact, patients with urological disorders or erectile dysfunction (ED) may have a sleep disorder that contributes to their urological or sexual dysfunction. Obstructive sleep apnea, insomnia, shift work disorder, and restless legs syndrome are all common sleep disorders and are associated with ED and/or other urological disorders. Therefore, careful attention should be paid to the diagnosis and treatment of concomitant sleep disorders in patients with sexual dysfunction. In this review, we provide an overview of what sleep is and how it is assessed in the clinic or laboratory; our current understanding of the functions of sleep and sleep health; a description of common sleep disorders, as well as how they are diagnosed and treated; and how sleep and its disorders are associated with male sexual dysfunction. Sleep is considered to be a ‘third pillar of health’, along with diet and exercise. With an understanding of common sleep disorders and how they can impact male sexual function, the urologist can ensure that sleep disorders are considered as a contributor to sexual dysfunction in their patients in order to provide them with the optimal treatment for overall health.
Diagnosis
;
Diet
;
Erectile Dysfunction
;
Humans
;
Male
;
Mental Health
;
Restless Legs Syndrome
;
Sexual Dysfunctions, Psychological
;
Sleep Apnea, Obstructive
;
Sleep Initiation and Maintenance Disorders
;
Sleep Wake Disorders
;
Testosterone
3.Diagnosis and treatment of sexual dysfunction in elderly men
Journal of the Korean Medical Association 2019;62(6):308-314
Male sexual dysfunction refers to a phenomenon in which a man experiences difficulty at any stage during the process of sexual intercourse. In general, erectile dysfunction is regarded as the most representative form of sexual dysfunction, but various other diseases can also be categorized as male sexual dysfunction, including sexual arousal disorder, decreased libido, ejaculation disorder, and Peyronie's disease. Causes of sexual dysfunction include chronic diseases, such as diabetes, hypertension, dyslipidemia, and obesity. In addition, some medications, surgical procedures, and traumas can cause sexual dysfunction. However, aging is the most important cause of male sexual dysfunction. To diagnose and treat elderly patients who complain of male sexual dysfunction, it is first necessary to become familiar with the characteristics of sexual dysfunction in elderly men. The prevalence rates of metabolic syndrome, hypertension, diabetes, dyslipidemia, coronary artery disease, stroke, and depression are higher among elderly men than among younger men; furthermore, the elderly are at a higher risk for the development of kidney, hepatic, spinal cord, and neurological diseases. Notably, anti-hypertensive agents can affect erectile function in elderly men: sexual dysfunction may be severe or the response to treatment may be poor. For satisfactory treatment, spousal factors should also be considered.
Aged
;
Aging
;
Antihypertensive Agents
;
Chronic Disease
;
Coitus
;
Coronary Artery Disease
;
Depression
;
Diagnosis
;
Dyslipidemias
;
Ejaculation
;
Erectile Dysfunction
;
Eunuchism
;
Humans
;
Hypertension
;
Kidney
;
Libido
;
Male
;
Obesity
;
Penile Induration
;
Prevalence
;
Sexual Dysfunction, Physiological
;
Sexual Dysfunctions, Psychological
;
Spinal Cord
;
Stroke
;
Testosterone
4.Penile sensory thresholds in subtypes of premature ejaculation: implications of comorbid erectile dysfunction.
Xiang CHEN ; Fei-Xiang WANG ; Chao HU ; Nian-Qin YANG ; Ji-Can DAI
Asian Journal of Andrology 2018;20(4):330-335
Penile hypersensitivity plays an important role in premature ejaculation (PE), but differences in penile sensitivity among subtypes of PE are unknown. Therefore, we compared penile sensory thresholds in PE subtypes of lifelong and acquired PE, PE with and without erectile dysfunction (ED), PE with an intravaginal ejaculation latency time ≤1 min and >1 min, and PE with and without orgasmic pleasure perceptual dysfunction. During August 2014 to January 2016, 136 patients with PE were included. Penile warm, cold, and vibratory thresholds were measured. Data of clinical characteristics, sexual life, Premature Ejaculation Diagnostic Tool (PEDT) score, and the 5-item version of the International Index of Erectile Function (IIEF-5) score were collected. Vibratory thresholds of the PE with ED group were higher in the right coronal sulcus (median amplitude: 4.92 vs 3.65 μ m, P = 0.02) and the right penile shaft (median amplitude: 3.87 vs 3.30 μ m, P = 0.03), while differences in penile sensory thresholds between other subtypes were not significant. The median PEDT score was lower in the PE without ED group (12 vs 14, P < 0.001). The IIEF-5 and PEDT scores were negatively correlated (r = -0.29, P < 0.001). Patients with orgasmic pleasure perceptual dysfunction had a lower median IIEF-5 score (20 vs 21, P = 0.02). Patients with PE and ED had lower penile sensitivity, and ED was associated with more severe symptoms and weaker orgasmic pleasure perception. In men with PE, management of comorbid ED is necessary. In case of side effects in erectile function, topical anesthetics should be cautiously used in men with PE and ED.
Adolescent
;
Adult
;
Ejaculation
;
Erectile Dysfunction/physiopathology*
;
Humans
;
Male
;
Middle Aged
;
Orgasm
;
Penis/physiology*
;
Physical Stimulation
;
Pleasure
;
Premature Ejaculation/physiopathology*
;
Prospective Studies
;
Sensory Thresholds
;
Sexual Dysfunctions, Psychological
;
Sexuality
;
Surveys and Questionnaires
;
Temperature
;
Vibration
;
Young Adult
5.Sexual Dysfunction among Chinese Nurses: Prevalence and Predictors.
Yi Qun YANG ; Qian XU ; Wei Jun TONG ; Chun Lan GAO ; Hong Mei LI ;
Biomedical and Environmental Sciences 2017;30(3):229-234
This study aimed to estimate the prevalence of and identify the factors influencing female sexual dysfunction (FSD) among Chinese nurses. A cross-sectional survey was conducted from March 2013 to May 2014 among 6 hospitals in Suzhou, China. In total, 2,030 married female nurses were included in the analysis. Data on the sociodemographic, lifestyle, and self-reported health status of the participants were collected, and the participants were asked to complete the Chinese version of the 19-item Female Sexual Function Index (FSFI) questionnaire. In total, 1,035 (50.99%) participants were found to have FSD. Logistic regression analysis showed that increasing age and higher body mass index, lower salary, and poor/very poor self-reported health status were risk factors for FSD; however, regular social activity and physical exercise were protective factors for FSD. The findings of this study suggest that further interventional studies are warranted to study the sexual health among Chinese nurses in detail.
Adult
;
Age Factors
;
Asian Continental Ancestry Group
;
China
;
epidemiology
;
Cross-Sectional Studies
;
Data Collection
;
Female
;
Humans
;
Middle Aged
;
Nurses
;
Prevalence
;
Sexual Dysfunction, Physiological
;
epidemiology
;
Sexual Dysfunctions, Psychological
;
epidemiology
;
Socioeconomic Factors
;
Surveys and Questionnaires
;
Young Adult
6.Influence of photoselective vaporization of the prostate on the sexual function of the patient.
Hua-Jie ZHANG ; Guo-Sheng YANG
National Journal of Andrology 2017;23(12):1127-1131
n recent years, photoselective vaporization of the prostate (PVP) has gained a wide clinical application in the treatment of benign prostatic hyperplasia (BPH) for its satisfactory effect, high safety, and low incidence of complications. With the improvement of living conditions, BPH patients are paying more attention to their sexual function, especially erectile function and ejaculatory problems instead of just focusing on the alleviation of lower urinary tract symptoms. Few studies of PVP, however, relate to its association with the sexual function of the patient and there is a certain controversy over the influence of PVP on it in the existing literature. Prevailing views hold that the uprated power in PVP does not affect erectile function or increase the risk of retrograde ejaculation (REj) and that PVP is even better than transurethral resection of the prostate (TURP) in avoiding the risk of REj.
Aged
;
Ejaculation
;
Humans
;
Laser Therapy
;
methods
;
Lower Urinary Tract Symptoms
;
therapy
;
Male
;
Penile Erection
;
Prostate
;
surgery
;
Prostatic Hyperplasia
;
surgery
;
Sexual Dysfunctions, Psychological
;
Transurethral Resection of Prostate
;
Treatment Outcome
7.Flibanserin for Treating Hypoactive Sexual Desire Disorder.
Jae Hong SANG ; Tae Hee KIM ; Soo Ah KIM
Journal of Menopausal Medicine 2016;22(1):9-13
There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD.
Brain
;
Citric Acid
;
Female
;
Hand
;
Humans
;
Korea
;
Male
;
Sexual Behavior
;
Sexual Dysfunctions, Psychological*
;
United States Food and Drug Administration
;
Sildenafil Citrate
;
Tadalafil
8.Pharmacologic management of female sexual dysfunction.
Journal of the Korean Medical Association 2016;59(2):136-143
In female sexual dysfunction (FSD), psychological and contextual factors significantly influence organic components of sexual response and behavior. The hormonal environment also affects FSD. Therefore, a tailored medical approach to each individual's sexual symptom is inevitable. This paper reviews currently available pharmacological treatment of FSD including the most recent advances and future targets in pharmacotherapy. In hormonal therapies for FSD, efficacy of estrogens and androgens on the treatment of vaginal atrophy, low sexual desire, and small subsets of genital arousal disorder, respectively, have been demonstrated. However, we need more data regarding long-term safety. There are two non-hormonal agents approved by the US Food and Drug Administration. Flibanserin has shown marginal benefit over placebo for the treatment of hypoactive sexual desire disorder. Ospemifen has shown beneficial effect on vulvovaginal pain from hormone related atrophy although it requires a longer period data to assess safety in other female genital organs, such as uterus and ovaries. Controversies still remain regarding hormonal therapies for FSD. Besides, some of the developing drugs still require more reliable safety and efficacy data. However, pharmacologic treatment of FSD is a promising field yet to be explored.
Androgens
;
Arousal
;
Atrophy
;
Drug Therapy
;
Estrogens
;
Female*
;
Genitalia, Female
;
Humans
;
Ovary
;
Sexual Dysfunctions, Psychological
;
United States Food and Drug Administration
;
Uterus
9.Sexual Pain Disorder with Anxiety and Depressive Psychopathology as Complication: A Case-Report
Ameerah Adeelah MA ; Kanit TD ; Hatta S
Medicine and Health 2016;11(1):87-91
Vaginismus is a sexual dysfunction which results from vaginal musculature spasm
and makes the penetration almost impossible. It is commonly associated with
significant emotional distress. On several occasions, fear of pain during sexual
intercourse may perpetuate the sexual dysfunction. We report a case of primary
vaginismus that was associated with psychiatric squeale of anxiety and depression
psychopathology. It suggests that psychological problems related to a mentalhealth
problem in vaginismus should be dealt adequately for a holistic approach.
A combination of behavioural, psychological and pharmacological treatment is
important to ensure a good prognosis outcome.
Vaginismus
;
Sexual Dysfunctions, Psychological
10.Premature ejaculation and female partners' psychological factors.
Jing-Jing GAO ; Xian-Sheng ZHANG
National Journal of Andrology 2013;19(1):86-89
Premature ejaculation (PE) is a most common sexual dysfunction in males, which variably affects men's reproductive and mental health. Recent studies show that PE affects not only the patients themselves, but also the psychological state of their spouses, which, in turn, may alleviate or aggravate the patients'PE symptoms by different reactions. However, the correlation between PE and female's psychological factors is mostly ignored by the patients and even clinicians in the studies, diagnosis and treatment of PE.
Female
;
Humans
;
Male
;
Sexual Dysfunction, Physiological
;
psychology
;
Sexual Dysfunctions, Psychological
;
etiology
;
Sexual Partners
;
psychology
;
Spouses
;
psychology

Result Analysis
Print
Save
E-mail